Obesity and weight loss in idiopathic intracranial hypertension: a narrative review
Table 1), 34 patients (64.2%) had recurrent depression, 15 (28.3%) had bipolar disorder and 4 patients (7.5%) had a single depressive episode (DE)
Evidence from SUSTAIN trials Across multiple phase 3 trials (SUSTAIN 16 and additional studies), semaglutide consistently produced greater reductions in glycated hemoglobin (HbA1c
On May 5, 2026, one of those nominators clarified its position
EASD Annual Meeting, 913 September, 2024.
Many patients find that GI side effects improve after completing the dose escalation period, though some may experience persistent symptoms